scispace - formally typeset
C

Carsten Culmsee

Researcher at University of Marburg

Publications -  172
Citations -  13392

Carsten Culmsee is an academic researcher from University of Marburg. The author has contributed to research in topics: Neuroprotection & Programmed cell death. The author has an hindex of 60, co-authored 166 publications receiving 11846 citations. Previous affiliations of Carsten Culmsee include University of Giessen & Ludwig Maximilian University of Munich.

Papers
More filters
Journal ArticleDOI

Glutathione Peroxidase 4 Senses and Translates Oxidative Stress into 12/15-Lipoxygenase Dependent- and AIF-Mediated Cell Death

TL;DR: It is demonstrated that oxidative stress is sensed and transduced by glutathione peroxidase 4 (GPx4) into a-yet-unrecognized cell-death pathway, and the identified pathway reveals promising targets for future therapies.
Journal ArticleDOI

Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity

TL;DR: The PARP inhibitor 3-aminobenzamide (3AB) protects neurons against homocysteine-induced NAD depletion, loss of mitochondrial transmembrane potential, and cell death, demonstrating a requirement for PARP activation and/or NAD depletion in homocystite-induced apoptosis.
Journal ArticleDOI

Roles of Nuclear Factor κB in Neuronal Survival and Plasticity

TL;DR: The NF-kappaB was first shown to mediate anti-apoptotic actions of tumor necrosis factor in cultured neurons and was subsequently shown to prevent death of various nonneuronal cells.
Journal ArticleDOI

Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer.

TL;DR: Nonviral vectors based on polyethylenimine usually contain an excess of PEI that is not complexed to DNA, which contributes to cellular and systemic toxicity, and purification of polyplexes from unbound PEI is desirable.
Journal ArticleDOI

p53 in neuronal apoptosis.

TL;DR: Preclinical data suggest that agents that inhibit p53 may be effective therapeutics for several neurodegenerative conditions.